{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:33:43Z","timestamp":1760240023623,"version":"build-2065373602"},"reference-count":43,"publisher":"IOP Publishing","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The incidence of highly aggressive pancreatic cancer is increasing across the globe and is projected to increase to 18.6% by 2050. The mortality rate for this form of cancer is very high and the 5 y relative survival rate is only about 9%\u201310%. The 3D pancreatic cancer microenvironment exerts a major influence on the poor survival rate. A key factor is the prevention of the penetration of the chemotherapeutic drugs in the three-dimensional (3D) microenvironment leading to the development of chemoresistance which is a major contributor to the survival rates. Hence, <jats:italic>in vitro<\/jats:italic> studies using 3D cultures represent a better approach to understand the effect of therapeutic formulations on the cancer cells when compared to conventional 2D cultures. In the present study, we have explored three different conditions for the development of a 3D pancreatic tumour spheroid model from MiaPaCa-2 and PanC1 cells cultured for 10 days using Matrigel matrix. This optimized spheroid model was employed to evaluate a multi-functional nanotheranostic system fabricated using chitosan nanoparticles co-encapsulated with the chemotherapeutic agent gemcitabine and gold-capped iron oxide nanoparticles for multimodal imaging. The effect of the single and multiple-dose regimens of the theranostic system on the viability of 3D spheroids formed from the two pancreatic cancer cell lines was studied. It was observed that the 3D tumour spheroids cultured for 10 days exhibited resistance towards free gemcitabine drug, unlike the 2D culture. The administration of the multifunctional nanotheranostic system on alternate days effectively reduced the cancer cell viability after five doses to about 20% when compared with other groups. The repeated doses of the nanotheranostic system were found to be more effective than the single dose. Cell line-based differences in internalization of the carrier was also reflected in their response to the nanocarrier with PanC1 showing better sensitivity to the treatment. <jats:italic>In vivo<\/jats:italic> studies revealed that the combination of gemcitabine and magnetic field induced hypothermia produced superior regression in cancer when compared with the chemotherapeutic agent alone by a combination of activating the pro-apoptotic pathway and heat-induced necrosis. Our results reveal that this multi-functional system holds promise to overcome the current challenges to treat pancreatic cancers.<\/jats:p>","DOI":"10.1088\/1748-605x\/ac9cb2","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T19:25:07Z","timestamp":1666380307000},"page":"015003","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigations of an organic\u2013inorganic nanotheranostic hybrid for pancreatic cancer therapy using cancer-in-a-dish and <i>in vivo<\/i> models"],"prefix":"10.1088","volume":"18","author":[{"given":"Karolyn Infanta","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T S","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-3990","authenticated-orcid":true,"given":"Swaminathan","family":"Sethuraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-4485","authenticated-orcid":true,"given":"Uma Maheswari","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"bmmac9cb2bib1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","type":"journal-article","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"key":"bmmac9cb2bib2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","type":"journal-article","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"bmmac9cb2bib3","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1038\/s41598-020-64068-3","type":"journal-article","article-title":"Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"key":"bmmac9cb2bib4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pharmthera.2015.06.006","type":"journal-article","article-title":"Modulation of the tumor vasculature and oxygenation to improve therapy","volume":"153","author":"Siemann","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"bmmac9cb2bib5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","type":"journal-article","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"bmmac9cb2bib6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","type":"journal-article","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov. Today"},{"key":"bmmac9cb2bib7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","type":"journal-article","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"bmmac9cb2bib8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","type":"journal-article","article-title":"2D and 3D cell cultures\u2014a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"bmmac9cb2bib9","doi-asserted-by":"publisher","first-page":"45745","DOI":"10.18632\/oncotarget.9935","type":"journal-article","article-title":"The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance","volume":"7","author":"Breslin","year":"2016","journal-title":"Oncotarget"},{"key":"bmmac9cb2bib10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31138-6","type":"journal-article","article-title":"Development of a novel 3D Tumor-tissue invasion model for high-throughput, high-content phenotypic drug screening","volume":"8","author":"Puls","year":"2018","journal-title":"Sci. Rep."},{"key":"bmmac9cb2bib11","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.3892\/ol.2017.7134","type":"journal-article","article-title":"Three-dimensional cell culture: a powerful tool in tumor research and drug discovery","volume":"14","author":"Lv","year":"2017","journal-title":"Oncol. Lett."},{"key":"bmmac9cb2bib12","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41598-020-59368-7","type":"journal-article","article-title":"Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development","volume":"10","author":"Nelson","year":"2020","journal-title":"Sci. Rep."},{"key":"bmmac9cb2bib13","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/nm.3973","type":"journal-article","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat. Med."},{"key":"bmmac9cb2bib14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9301382","type":"journal-article","article-title":"Pancreatic progenitors and organoids as a prerequisite to model pancreatic diseases and cancer","volume":"2019","author":"Hohwieler","year":"2019","journal-title":"Stem Cells Int."},{"key":"bmmac9cb2bib15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/1535370216643772","type":"journal-article","article-title":"Liquid-based three-dimensional tumor models for cancer research and drug discovery","volume":"241","author":"Ham","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"bmmac9cb2bib16","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/ma12182945","type":"journal-article","article-title":"The tumor-on-chip: recent advances in the development of microfluidic systems to recapitulate the physiology of solid tumors","volume":"12","author":"Trujillo-de Santiago","year":"2019","journal-title":"Materials"},{"key":"bmmac9cb2bib17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ten.teb.2012.0437","type":"journal-article","article-title":"Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size tissue","volume":"19","author":"Loh","year":"2013","journal-title":"Eng. Rev. B"},{"key":"bmmac9cb2bib18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","type":"journal-article","article-title":"Synthetic alternatives to Matrigel","volume":"5","author":"Aisenbrey","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"bmmac9cb2bib19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1021\/acs.bioconjchem.9b00136","type":"journal-article","article-title":"Penetration and uptake of nanoparticles in 3D tumor spheroids","volume":"30","author":"Tchoryk","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"bmmac9cb2bib20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/cancers13020195","type":"journal-article","article-title":"Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers"},{"key":"bmmac9cb2bib21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.msec.2019.01.013","type":"journal-article","article-title":"Magnetic targeting core\/shell Fe3O4\/Au nanoparticles for magnetic resonance\/photoacoustic dual-modal imaging","volume":"98","author":"Kang","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"bmmac9cb2bib22","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1039\/C7NR01064H","type":"journal-article","article-title":"AuGd integrated nanoprobes for optical\/MRI\/CT triple-modal in vivo tumor imaging","volume":"9","author":"Xu","year":"2017","journal-title":"Nanoscale"},{"key":"bmmac9cb2bib23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.7150\/thno.48811","type":"journal-article","article-title":"MRI-traceable theranostic nanoparticles for targeted cancer treatment","volume":"11","author":"Anani","year":"2021","journal-title":"Theranostics"},{"key":"bmmac9cb2bib24","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ac177c","type":"journal-article","article-title":"Development and evaluation of a multi-functional organic\u2013inorganic nanotheranostic hybrid for pancreatic cancer therapy","volume":"16","author":"David","year":"2021","journal-title":"Biomed. Mater."},{"key":"bmmac9cb2bib25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13007-019-0430-z","type":"journal-article","article-title":"Accurate and efficient amino acid analysis for protein quantification using hydrophilic interaction chromatography coupled tandem mass spectrometry","volume":"15","author":"Kambhampati","year":"2019","journal-title":"Plant Methods"},{"key":"bmmac9cb2bib26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","type":"journal-article","article-title":"Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell. Metab."},{"key":"bmmac9cb2bib27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-12-391858-1.00011-3","type":"journal-article","article-title":"Chapter ten\u2014investigating the toxic effects of iron oxide nanoparticles","volume":"509","author":"Soenen","year":"2012","journal-title":"Methods Enzymol."},{"key":"bmmac9cb2bib28","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1038\/ijos.2017.51","type":"journal-article","article-title":"Analysis of differential expression of tight junction proteins in cultured oral epithelial cells altered by porphyromonas gingivalis, porphyromonas gingivalis lipopolysaccharide, and extracellular adenosine triphosphate","volume":"10","author":"Guo","year":"2018","journal-title":"Int. J. Oral Sci."},{"key":"bmmac9cb2bib29","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2672740","type":"journal-article","article-title":"Hybrid nanomaterials based on iron oxide nanoparticles and mesoporous silica nanoparticles: overcoming challenges in current cancer treatments","volume":"2016","author":"Alvarez-Berr\u00edos","year":"2016","journal-title":"J. Chem."},{"key":"bmmac9cb2bib30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.semcancer.2005.05.002","type":"journal-article","article-title":"Three-dimensional tissue culture models in cancer biology","volume":"15","author":"Kim","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"bmmac9cb2bib31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biomaterials.2015.09.017","type":"journal-article","article-title":"3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma","volume":"73","author":"de la Puente","year":"2015","journal-title":"Biomaterials"},{"key":"bmmac9cb2bib32","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3892\/ijmm.2019.4284","type":"journal-article","article-title":"Induction of ROS-mediated cell death and activation of the JNK pathway by a sulfonamide derivative","volume":"44","author":"Ahmad","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"bmmac9cb2bib33","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1038\/s41598-021-86028-1","type":"journal-article","article-title":"Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures","volume":"11","author":"Minami","year":"2021","journal-title":"Sci. Rep."},{"key":"bmmac9cb2bib34","doi-asserted-by":"publisher","DOI":"10.1038\/srep21648","type":"journal-article","article-title":"MIA PaCa-2 and PANC-1\u2014pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors","volume":"6","author":"Gradiz","year":"2016","journal-title":"Sci. Rep."},{"key":"bmmac9cb2bib35","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/jat.3485","type":"journal-article","article-title":"Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes","volume":"37","author":"Gaharwar","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"bmmac9cb2bib36","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","type":"journal-article","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta\u2014Mol. Cell Res."},{"key":"bmmac9cb2bib37","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","type":"journal-article","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"bmmac9cb2bib38","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/524308","type":"journal-article","article-title":"The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias","volume":"2012","author":"Tzifi","year":"2012","journal-title":"Adv. Hematol."},{"key":"bmmac9cb2bib39","first-page":"1617","type":"journal-article","article-title":"Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells Asian pacific","volume":"13","author":"Selim","year":"2012","journal-title":"J. Cancer Prev."},{"key":"bmmac9cb2bib40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.bjc.6602344","type":"journal-article","article-title":"Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix","volume":"92","author":"Green","year":"2005","journal-title":"Br. J. Cancer"},{"key":"bmmac9cb2bib41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0b013e3181bd51c8","type":"journal-article","article-title":"Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic whites: a case-control study","volume":"39","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"bmmac9cb2bib42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00280-007-0482-z","type":"journal-article","article-title":"A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging","volume":"61","author":"Bornmann","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"bmmac9cb2bib43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12079-012-0179-x","type":"journal-article","article-title":"Post-transcriptional regulation in cancer progression","volume":"6","author":"Jewer","year":"2012","journal-title":"J. Cell. Commun. Signal"}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:33:24Z","timestamp":1760186004000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ac9cb2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,10]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/ac9cb2","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"type":"print","value":"1748-6041"},{"type":"electronic","value":"1748-605X"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"Investigations of an organic\u2013inorganic nanotheranostic hybrid for pancreatic cancer therapy using cancer-in-a-dish and in vivo models","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2022 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2021-11-19","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2022-10-21","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2022-11-10","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}